Kanker usus halus Dokter Terbaik di Israel - TOP-17 dokter

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, yang berspesialisasi dalam tumor langka seperti kanker usus kecil.

• Lebih dari 25 tahun pengalaman onkologi, berfokus pada sarkoma dan kanker langka
• Penyelidik senior di Weizmann Institute dan Tel-Aviv University
• Anggota Fakultas Sarkoma ESMO dan komite etika IASLC
• Terlatih di Institut Gustave Roussy, Paris – pusat sarkoma terkemuka di Eropa

Dr. Pelles Sharon berspesialisasi dalam perawatan kanker tingkat lanjut, termasuk kanker usus kecil, di Sourasky Medical Center (Ichilov).

• Menawarkan berbagai perawatan bedah dan non-bedah seperti terapi SIRT dan HIPEC
• Aktif dalam penelitian klinis, berkontribusi pada studi tentang sikap pasien onkologi
• Menyediakan opsi imunoterapi dan terapi bertarget
• Ahli dalam bedah kanker hati dan pankreas

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Wolf memimpin Divisi Onkologi Medis di Sourasky Medical Center, salah satu rumah sakit terbesar dan terkemuka di Israel.

• Memimpin divisi yang menangani kanker gastrointestinal yang kompleks
• Memiliki gelar dan pelatihan ekstensif dalam onkologi medis
• Berpengalaman dalam mengelola kasus kanker langka seperti kanker usus halus
• Bekerja di pusat medis akademik utama untuk protokol perawatan tingkat lanjut

Dr. Greenberg adalah spesialis terkemuka dalam operasi Whipple – sebuah prosedur kunci untuk kanker usus halus – dan mengepalai Departemen Bedah Kolorektal di Sourasky Medical Center.

• Pengalaman lebih dari 20 tahun sebagai ahli bedah abdomen
• Melakukan teknik bedah terbuka maupun invasif minimal
• Memimpin departemen khusus di rumah sakit tersier utama

Direktur rawat inap onkologi di Tel Aviv Medical Center – Dr. Stepfansky memimpin unit onkologi khusus dengan fokus pada kanker usus halus.

• Pengalaman lebih dari 25 tahun di bidang onkologi dan penyakit dalam
• Peneliti utama dan sekunder dalam uji klinis fase 1-3
• Terlatih di Tel Aviv Medical Center, salah satu rumah sakit terkemuka di Israel
• Spesialisasi dalam diagnosis dan pengobatan kanker usus halus

Dr. Klauzner diakui sebagai salah satu ahli bedah Whipple terbaik di Israel – sebuah prosedur kompleks untuk tumor pada sistem pencernaan. Beliau mengepalai departemen bedah di Sourasky Medical Center (Ichilov).

• Menspesialisasi dalam bedah kanker gastrointestinal, pankreas, dan kolorektal
• Pengalaman bedah lebih dari 45 tahun
• Memegang posisi senior sebagai Ketua Bedah

33 tahun spesialisasi dalam onkologi dan radioterapi – Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center.

• Tersertifikasi dewan dalam onkologi dan radioterapi
• Lulusan Rumah Sakit Universitas Hadassah
• Fasih berbahasa Inggris dan Ibrani
• Anggota dari berbagai asosiasi onkologi

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Wakil Kepala Departemen Onkologi di Rambam Medical Center – peran utama dalam perawatan kanker.

• Spesialisasi dalam pengobatan kanker usus halus
• Bekerja di pusat medis terkemuka di Israel
• Memegang posisi kepemimpinan di bidang onkologi

Dr. Alexander Beny adalah Direktur Layanan Keganasan Gastrointestinal di Rambam Medical Center, yang berspesialisasi dalam kanker usus kecil.

• Onkolog bersertifikat dewan dengan European Community Board Examination dalam Kedokteran
• Memimpin klinik Onkologi Gastrointestinal di Rambam Medical Center
• Terlatih dalam teknik Brakiterapi modern melalui kursus ESTRO
• Berpengalaman dalam pendekatan onkologi medis maupun radiasi

Dr. Gutman adalah seorang dokter bedah onkologi yang berspesialisasi dalam kanker usus halus di Assuta Medical Center.

• Berfokus pada onkologi bedah dengan keahlian dalam kasus usus halus
• Bekerja di Assuta Medical Center – rumah sakit onkologi terkemuka
• Memberikan rencana perawatan yang dipersonalisasi untuk setiap pasien

Spesialis bedah endoskopi – Dr. Kashtan berfokus pada teknik invasif minimal untuk kanker usus halus di Assuta Medical Center.

• Terlatih dalam prosedur endoskopi tingkat lanjut
• Bekerja di salah satu pusat onkologi terkemuka di Israel
• Keahlian dalam pengobatan kanker usus halus

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.